Clinical trial
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging…
NCT00096720 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00096720 |
|---|---|
| Title | Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease |
| Official title | Investigating Effects of Short-term Treatment With Pramipexole or Levodopa on [123I]B-CIT and SPECT Imaging in Early Parkinson's |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | Boehringer Ingelheim Industry United States Department of Defense U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease, Parkinsonian Syndrome |
| Intervention type | Drug, Procedure |
| Interventions | levodopa, Mirapex (pramipexole), [123I]ß-CIT and SPECT imaging |
| Enrollment | 112 |
| Start date | Feb 1, 2004 |
| Completion | May 1, 2007 |
| First posted | Nov 15, 2004 |
| Last update posted | Sep 29, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: